{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:58:42Z","timestamp":1788001122055,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T00:00:00Z","timestamp":1528848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1208\/s12249-018-1094-0","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T14:22:37Z","timestamp":1528899757000},"page":"2554-2563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Improved Ocular Delivery of Nepafenac by Cyclodextrin Complexation"],"prefix":"10.1208","volume":"19","author":[{"given":"Haley","family":"Shelley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makenzie","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forrest T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Abarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jayachandra Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"issue":"6","key":"1094_CR1","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1345\/aph.1R757","volume":"47","author":"BM Jones","year":"2013","unstructured":"Jones BM, Neville MW. Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery. Ann Pharmacother. 2013;47(6):892\u20136.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"1094_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2147\/OPTH.S1067","volume":"2","author":"BI Gaynes","year":"2008","unstructured":"Gaynes BI, Onyekwuluje A. Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension. Clin Ophthalmol. 2008;2(2):355\u201368.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"1094_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1208\/s12248-008-9024-9","volume":"10","author":"M Ahuja","year":"2008","unstructured":"Ahuja M, Dhake AS, Sharma SK, Majumdar DK. Topical ocular delivery of NSAIDs. AAPS J. 2008;10(2):229\u201341.","journal-title":"AAPS J"},{"issue":"9","key":"1094_CR4","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.jcrs.2007.05.015","volume":"33","author":"T Walters","year":"2007","unstructured":"Walters T, Raizman M, Ernest P, Gayton J, Lehmann R. In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. J Cataract Refract Surg. 2007;33(9):1539\u201345.","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"1094_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","volume":"2","author":"A Patel","year":"2013","unstructured":"Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2(2):47\u201364.","journal-title":"World J Pharmacol"},{"key":"1094_CR6","unstructured":"Saettone, M.F., Progress and problems in ophthalmic drug delivery, in Future Drug Delivery. 2002, University of Pisa. p. 167\u2013171."},{"key":"1094_CR7","unstructured":"Pharmacy, U.o.N.C.E.S.o. Sterile compounding: ophthalmics. [cited 2015 08\/21]."},{"issue":"6","key":"1094_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/jps.2600640606","volume":"64","author":"JW Sieg","year":"1975","unstructured":"Sieg JW, Robinson JR. Vehicle effects on ocular drug bioavailability i: evaluation of fluorometholone. J Pharm Sci. 1975;64(6):931\u20136.","journal-title":"J Pharm Sci"},{"issue":"11","key":"1094_CR9","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jcrs.2007.07.017","volume":"33","author":"HVQ Duong","year":"2007","unstructured":"Duong HVQ, Westfield KC, Chalkley THF. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery\u2014prospective randomized double-masked clinical trial. J Cataract Refract Surg. 2007;33(11):1925\u20139.","journal-title":"J Cataract Refract Surg"},{"issue":"11","key":"1094_CR10","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3109\/03639049109026630","volume":"17","author":"O Bekers","year":"1991","unstructured":"Bekers O, Uijtendaal EV, Beijnen JH, Bult A, Underberg WJM. Cyclodextrins in the pharmaceutical field. Drug Dev Ind Pharm. 1991;17(11):1503\u201349.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1\u20132","key":"1094_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1014520830813","volume":"42","author":"L Liu","year":"2002","unstructured":"Liu L, Guo QX. The driving forces in the inclusion complexation of cyclodextrins. J Incl Phenom Macrocycl Chem. 2002;42(1\u20132):1\u201314.","journal-title":"J Incl Phenom Macrocycl Chem"},{"issue":"9","key":"1094_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0032-9592(03)00258-9","volume":"39","author":"EMM Valle Del","year":"2004","unstructured":"Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem. 2004;39(9):1033\u201346.","journal-title":"Process Biochem"},{"issue":"3\u20134","key":"1094_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.drudis.2007.10.021","volume":"13","author":"SK Sahoo","year":"2008","unstructured":"Sahoo SK, Diinawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today. 2008;13(3\u20134):144\u201351.","journal-title":"Drug Discov Today"},{"issue":"5","key":"1094_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/03639049709148496","volume":"23","author":"T Loftsson","year":"1997","unstructured":"Loftsson T, Stefansson E. Effect of cyclodextrins on topical drug delivery to the eye. Drug Dev Ind Pharm. 1997;23(5):473\u201381.","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"1094_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/0975-7406.67003","volume":"2","author":"G Tiwari","year":"2010","unstructured":"Tiwari G, Tiwari R, Rai AK. Cyclodextrins in delivery systems: applications. J Pharm Bioallied Sci. 2010;2(2):72\u20139.","journal-title":"J Pharm Bioallied Sci"},{"issue":"1","key":"1094_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1773-2247(07)50001-8","volume":"17","author":"T Loftsson","year":"2007","unstructured":"Loftsson T, Stefansson E. Cyclodextrins in ocular drug delivery: theoretical basis with dexamethasone as a sample drug. Journal of Drug Delivery Science and Technology. 2007;17(1):3\u20139.","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"8","key":"1094_CR17","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1248\/cpb.52.900","volume":"52","author":"K Uekama","year":"2004","unstructured":"Uekama K. Design and evaluation of cyclodextrin-based drug formulation. Chem Pharm Bull (Tokyo). 2004;52(8):900\u201315.","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"2","key":"1094_CR18","doi-asserted-by":"publisher","first-page":"E329","DOI":"10.1208\/pt060243","volume":"6","author":"R Challa","year":"2005","unstructured":"Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech. 2005;6(2):E329\u201357.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"1094_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0169-409X(98)00055-6","volume":"36","author":"T Loftssona","year":"1999","unstructured":"Loftssona T, Jarvinen T. Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev. 1999;36(1):59\u201379.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3\u20134","key":"1094_CR20","first-page":"459","volume":"7","author":"T Jansen","year":"1990","unstructured":"Jansen T, Xhonneux B, Mesens J, Borgers M. Beta-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effecst on rabbit corneal epithelium. Lens Eye Toxic Res. 1990;7(3\u20134):459\u201368.","journal-title":"Lens Eye Toxic Res"},{"key":"1094_CR21","unstructured":"Jonathan C. Javitt, N.B.J., Peter Mcdonnell, Topical compositions for the eye comprising a beta-cyclodextrin derivative and a carbonic anhydrase inhibitor 1994."},{"issue":"4","key":"1094_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0021-9290(00)00219-0","volume":"34","author":"YJ Zeng","year":"2001","unstructured":"Zeng YJ, Yang J, Huang K, Lee ZH, Lee XY. A comparison of biomechanical properties between human and porcine cornea. J Biomech. 2001;34(4):533\u20137.","journal-title":"J Biomech"},{"key":"1094_CR23","first-page":"117","volume":"4","author":"T Higuchi","year":"1965","unstructured":"Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum. 1965;4:117\u2013212.","journal-title":"Adv Anal Chem Instrum"},{"issue":"1","key":"1094_CR24","first-page":"116","volume":"28","author":"GRA Eleamen","year":"2017","unstructured":"Eleamen GRA, da Costa SC, Lima-Neto RG, Neves RP, Rolim LA, Rolim-Neto PJ, et al. Improvement of solubility and antifungal activity of a new aminothiophene derivative by complexation with 2-hydroxypropyl-beta-cyclodextrin. J Braz Chem Soc. 2017;28(1):116\u201325.","journal-title":"J Braz Chem Soc"},{"issue":"8","key":"1094_CR25","first-page":"2593","volume":"43","author":"CC Chen","year":"2002","unstructured":"Chen CC, Chang JH, Lee JB, Javier J, Azar DT. Human corneal epithelial cell viability and morphology after dilute alcohol exposure. Invest Ophthalmol Vis Sci. 2002;43(8):2593\u2013602.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"1094_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1089\/jop.2013.0063","volume":"29","author":"EM Abarca","year":"2013","unstructured":"Abarca EM, Salmon JH, Gilger BC. Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model. J Ocul Pharmacol Ther. 2013;29(8):715\u201322.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"1094_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ejpb.2011.11.006","volume":"80","author":"J Mains","year":"2012","unstructured":"Mains J, Tan LE, Wilson C, Urquhart A. A pharmacokinetic study of a combination of beta adrenoreceptor antagonists\u2014in the isolated perfused ovine eye. Eur J Pharm Biopharm. 2012;80(2):393\u2013401.","journal-title":"Eur J Pharm Biopharm"},{"key":"1094_CR28","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.carbpol.2016.04.022","volume":"147","author":"Y Liao","year":"2016","unstructured":"Liao Y, Zhang X, Li C, Huang Y, Lei M, Yan M, et al. Inclusion complexes of HP-beta-cyclodextrin with agomelatine: preparation, characterization, mechanism study and in vivo evaluation. Carbohydr Polym. 2016;147:415\u201325.","journal-title":"Carbohydr Polym"},{"issue":"2","key":"1094_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4103\/0975-7406.171680","volume":"8","author":"DM Bramhane","year":"2016","unstructured":"Bramhane DM, Kulkarni PA, Martis EA, Pissurlenkar RR, Coutinho EC, Nagarsenker MS. Characterization of pioglitazone cyclodextrin complexes: molecular modeling to in vivo evaluation. J Pharm Bioallied Sci. 2016;8(2):161\u20139.","journal-title":"J Pharm Bioallied Sci"},{"key":"1094_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.carbpol.2015.05.055","volume":"131","author":"P Tang","year":"2015","unstructured":"Tang P, Li S, Wang L, Yang H, Yan J, Li H. Inclusion complexes of chlorzoxazone with beta- and hydroxypropyl-beta-cyclodextrin: characterization, dissolution, and cytotoxicity. Carbohydr Polym. 2015;131:297\u2013305.","journal-title":"Carbohydr Polym"},{"key":"1094_CR31","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.biopha.2016.08.030","volume":"83","author":"C Oprean","year":"2016","unstructured":"Oprean C, Mioc M, Csanyi E, Ambrus R, Bojin F, Tatu C, et al. Improvement of ursolic and oleanolic acids\u2019 antitumor activity by complexation with hydrophilic cyclodextrins. Biomed Pharmacother. 2016;83:1095\u2013104.","journal-title":"Biomed Pharmacother"},{"key":"1094_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijbiomac.2016.07.033","volume":"92","author":"P Tang","year":"2016","unstructured":"Tang P, Tang B, Wang Q, Xu K, Xiong X, Li H. Effect of hydroxypropyl-beta-cyclodextrin on the bounding of salazosulfapyridine to human serum albumin. Int J Biol Macromol. 2016;92:105\u201315.","journal-title":"Int J Biol Macromol"},{"key":"1094_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.carbpol.2016.01.042","volume":"142","author":"P Tang","year":"2016","unstructured":"Tang P, Ma X, Wu D, Li S, Xu K, Tang B, et al. Posaconazole\/hydroxypropyl-beta-cyclodextrin host-guest system: improving dissolution while maintaining antifungal activity. Carbohydr Polym. 2016;142:16\u201323.","journal-title":"Carbohydr Polym"},{"key":"1094_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tca.2013.10.007","volume":"575","author":"I Alves-Silva","year":"2014","unstructured":"Alves-Silva I, Sa-Barreto LCL, Lima EM, Cunha-Filho MSS. Preformulation studies of itraconazole associated with benznidazole and pharmaceutical excipients. Thermochim Acta. 2014;575:29\u201333.","journal-title":"Thermochim Acta"},{"issue":"10","key":"1094_CR35","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/jphp.12601","volume":"68","author":"EC Alonso","year":"2016","unstructured":"Alonso EC, Riccomini K, Silva LA, Galter D, Lima EM, Durig T, et al. Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages. J Pharm Pharmacol. 2016;68(10):1299\u2013309.","journal-title":"J Pharm Pharmacol"},{"key":"1094_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jpba.2015.11.015","volume":"119","author":"MA Braga","year":"2016","unstructured":"Braga MA, Martini MF, Pickholz M, Yokaichiya F, Franco MK, Cabeca LF, et al. Clonidine complexation with hydroxypropyl-beta-cyclodextrin: from physico-chemical characterization to in vivo adjuvant effect in local anesthesia. J Pharm Biomed Anal. 2016;119:27\u201336.","journal-title":"J Pharm Biomed Anal"},{"key":"1094_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.foodchem.2016.07.155","volume":"215","author":"CL Zhang","year":"2017","unstructured":"Zhang CL, Liu JC, Yang WB, Chen DL, Jiao ZG. Experimental and molecular docking investigations on the inclusion mechanism of the complex of phloridzin and hydroxypropyl-beta-cyclodextrin. Food Chem. 2017;215:124\u20138.","journal-title":"Food Chem"},{"key":"1094_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.foodchem.2016.08.023","volume":"216","author":"A Matencio","year":"2017","unstructured":"Matencio A, Hernandez-Gil CJ, Garcia-Carmona F, Lopez-Nicolas JM. Physicochemical, thermal and computational study of the encapsulation of rumenic acid by natural and modified cyclodextrins. Food Chem. 2017;216:289\u201395.","journal-title":"Food Chem"},{"key":"1094_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.carbpol.2016.11.093","volume":"159","author":"YQ Wei","year":"2017","unstructured":"Wei YQ, Zhang J, Zhou Y, Bei WY, Li Y, Yuan QP, et al. Characterization of glabridin\/hydroxypropyl-beta-cyclodextrin inclusion complex with robust solubility and enhanced bioactivity. Carbohydr Polym. 2017;159:152\u201360.","journal-title":"Carbohydr Polym"},{"key":"1094_CR40","unstructured":"IR Spectroscopy Tutorials: Amines IR Spectroscopy Tutorials [cited 2017; Available from: \n                    www.orgchemboulder.com\/spectroscopy\/irtutor\/aminesir.shtml\n                    \n                  ."},{"key":"1094_CR41","doi-asserted-by":"crossref","unstructured":"Cuming RS, Abarca EM, Duran S, Wooldridge AA, Stewart AJ, Ravis W, Babu RJ, Lin YJ, Hathcock T. Development of a sustained-release voriconazole-containing thermogel for subconjunctival injection in horses. Invest Ophthalmol Vis Sci. 2017;58(5):2746\u20132754.","DOI":"10.1167\/iovs.16-20899"},{"issue":"1","key":"1094_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0168-3659(98)00182-5","volume":"59","author":"M Masson","year":"1999","unstructured":"Masson M, Loftsson T, Masson G, Stefansson E. Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J Control Release. 1999;59(1):107\u201318.","journal-title":"J Control Release"},{"issue":"4","key":"1094_CR43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ajps.2017.03.002","volume":"12","author":"K Tahara","year":"2017","unstructured":"Tahara K, Karasawa K, Onodera R, Takeuchi H. Feasibility of drug delivery to the eye's posterior segment by topical instillation of PLGA nanoparticles. Asian Journal of Pharmaceutical Sciences. 2017;12(4):394\u20139.","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"issue":"3","key":"1094_CR44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. Aaps Journal. 2010;12(3):348\u201360.","journal-title":"Aaps Journal"},{"issue":"12","key":"1094_CR45","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1021\/js9802594","volume":"87","author":"MR Prausnitz","year":"1998","unstructured":"Prausnitz MR, Noonan JS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87(12):1479\u201388.","journal-title":"J Pharm Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-1094-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1094-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1094-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T19:03:04Z","timestamp":1560366184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-1094-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,13]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-1094-0","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,13]]},"assertion":[{"value":"31 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}